1h Free Analyst Time
The artificial intelligence in biotechnology market is forecasted to grow by USD 4.46 billion during 2024-2029, accelerating at a CAGR of 19% during the forecast period. The report on the artificial intelligence in biotechnology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by investments in biotechnology advancements, prevalence of chronic diseases, and increase in number of artificial intelligence-based biotech laboratories.
The artificial intelligence in biotechnology market is segmented as below:
By Application
- Drug discovery and development
- Clinical trials and optimization
- Medical imaging
- Diagnostics
- Others
By End-user
- Pharmaceutical companies
- Biotechnology companies
- Contract research organization (CRO)
- Healthcare providers
- Others
By Geographical Landscape
- North America
- Europe
- APAC
- South America
- Middle East and Africa
The report on the artificial intelligence in biotechnology market covers the following areas:
- Artificial Intelligence In Biotechnology Market sizing
- Artificial Intelligence In Biotechnology Market forecast
- Artificial Intelligence In Biotechnology Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Application
9 Market Segmentation by End-user
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global artificial intelligence in biotechnology market: Abbott Laboratories, Amgen Inc., AstraZeneca Plc, BeiGene Ltd., Biogen Inc., Bristol Myers Squibb Co., CareDx Inc., Clario, F. Hoffmann La Roche Ltd., Genesis Therapeutics Inc., Insilico Medicine, Johnson and Johnson Inc., Merck KGaA, Novartis AG, Novo Nordisk AS, Pfizer Inc., Recursion Pharmaceuticals, Roivant Sciences Ltd., Sage Therapeutics Inc., and Sanofi SA.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is strategic collaborations."
According to the report, one of the major drivers for this market is the investments in biotechnology advancements.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Amgen Inc.
- AstraZeneca Plc
- BeiGene Ltd.
- Biogen Inc.
- Bristol Myers Squibb Co.
- CareDx Inc.
- Clario
- F. Hoffmann La Roche Ltd.
- Genesis Therapeutics Inc.
- Insilico Medicine
- Johnson and Johnson Inc.
- Merck KGaA
- Novartis AG
- Novo Nordisk AS
- Pfizer Inc.
- Recursion Pharmaceuticals
- Roivant Sciences Ltd.
- Sage Therapeutics Inc.
- Sanofi SA
